Identifying Market Opportunities Daily

Company Overview Tesla delivered a eventful Q4 2025 earnings report on January 29th—less than two weeks ago—posting revenue of $25.7 billion and automotive gross margins of 22.4% that exceeded analyst expectations. The company reported total vehicle deliveries of...

Company Overview ASML reported impressive Q4 2025 earnings on January 29th—just over a week ago—posting net sales of €9.3 billion (up 24% year-over-year) and net income of €2.7 billion that exceeded analyst expectations. More importantly, the Dutch semiconductor...

Company Overview Chipotle delivered blockbuster Q4 2025 earnings just two days ago on February 4th, reporting comparable restaurant sales growth of 15.2% that crushed analyst expectations of 11.3%. The company posted revenue of $2.9 billion (up 18.5% year-over-year)...

Company Overview Meta Platforms reports its highly anticipated Q4 2025 earnings today after market close, with analysts expecting revenue of $46.9 billion (up 16% year-over-year) and earnings per share of $6.78. The stock has been on a remarkable run, up over 60% in...

Company Overview Caterpillar delivered impressive Q4 2025 earnings just one week ago on January 28th, reporting adjusted earnings per share of $5.48 that beat analyst estimates of $5.12. The company posted revenue of $17.1 billion (up 4% year-over-year) while...

Company Overview Nike is in the early stages of what could be one of the most watched corporate turnarounds of 2026. The company brought back company veteran Elliott Hill as CEO in October 2025, replacing John Donahoe after years of market share losses to upstarts...

Company Overview Block delivered impressive Q4 2025 earnings just three days ago on January 30th, with results that exceeded analyst expectations across key metrics. The company reported gross profit of $2.25 billion (up 19% year-over-year) and revenue of $6.2...

Company Overview Eli Lilly delivered major clinical news on January 9, 2026, announcing positive extended Phase 3 results for donanemab, its Alzheimer's disease treatment. The TRAILBLAZER-ALZ 3 study showed patients on donanemab experienced 35% slower cognitive...

Company Overview AMD delivered a one-two punch of positive catalysts in early January, starting with Q4 2025 earnings that beat analyst expectations on January 7th, followed by a major announcement on January 10th that Microsoft selected AMD's MI300X AI accelerators...

Company Overview Lockheed Martin just received a major vote of confidence from the U.S. Department of Defense with a $7.3 billion contract modification awarded on January 16, 2026—less than two weeks ago. The contract covers production and delivery of F-35 Lightning...